TOP HEADLINES

Top Story

Liquidia touts promise of next-gen respiratory delivery

Liquidia Technologies' PRINT platform is a particle-engineering technology that has performed well in two recent studies.

MIT: Staggering cancer drugs can make them more effective

Researchers have come up with a method of staggering doses that has led to increased effectiveness of cancer drugs.

UNC researchers craft siRNA platform that can switch its solubility

Scientists at UNC have come up with a drug carrier that holds together in the blood stream and then dissolves once it reaches its target cells.

DNA origami could allow for 'autonomous' delivery

Researchers at Harvard's Wyss Institute are using the method to develop self-assembling, self-destructing drug delivery vessels.

Japanese firm buys Altea's assets, plans to launch transdermal tech

Nitto Denko has acquired all of Altea's assets, planning to use the company's transdermal technology to launch a patch on its own.

MORE NEWS

From Our Sister Sites

FierceCRO

Almost two years after receiving an FDA warning letter citing 9 violations at its Everett, WA, laboratory, SNBL USA announced that it remedied 7 of them. But while the U.S. subsidiary of Japanese CRO Shin Nippon Biomedical Laboratories is resolving its issues in one part of the world, it is caught up in an animal rights scandal in another.

 

FierceCRO

The Indiana CRO will have to reconfigure some of its lab operations in an effort to recoup losses, according to its second-quarter report.